ALL ABOUT MS Pregnancy and MS (Part 13)
Given that MS is largely a disease of women, and also of young women, there is a special topic of the relationship between this disease and pregnancy, or birth.
MS does not increase the risk of complications during pregnancy. It has not been shown that there is an increased incidence of preterm delivery, birth defects, inborn deformations, or early death of the newborn. However, exceptions are possible.
Delivery in women with MS does not differ from birth in healthy women. The method of delivery is determined by the gynecologist according to gynecological criteria. Previously, spinal anesthesia was thought to increase the risk of postpartum deterioration, but the use of modern epidural anesthesia is considered safe and has not been shown to increase the risk of deterioration after delivery.
Breastfeeding is recommended and does not increase the risk of deterioration. However, caution is needed if mothers take medicines that are secreted through milk. Breastfeeding is forbidden if the mother receives corticosteroids or mitoxantrone and is not recommended during interferon beta therapy and glatiramer acetate, as it is not known whether these drugs are excreted via breast milk.
It is known that pregnancy works favorably on the course of MS, reducing the risk of deterioration, which is particularly pronounced in the first trimester of pregnancy. On the other hand, the risk of MS worsening is rising immediately after delivery, especially in the first three months after delivery. It has not been shown that deterioration of MS during pregnancy and postpartum is more severe than other illnesses during illness. In the long term, the number of pregnancies and the way of delivery have no effect on the development of the disease and its progression. In any case, women with MS, especially those with mild neurological outbreaks, should be encouraged to establish a family as early as possible for a possible progressive course of the disease.
Comments
Post a Comment